Wedemeyer H, Alexandrov A, Bogo-molov P, et al. Interim results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection. AASLD 2017, abstract 37.
Specifieke overlevingscijfers beschikbaar op kanker.nl
aug 2023 | Borstkanker, Longoncologie, Maag-darm-leveroncologie, Uro-oncologie